Imepitoin in epileptic dogs: indications and limitations
Regarding imepitoin in dogs, which statement is correct?
chevron_right Show answer and explanation
A. It is the drug of choice in dogs with cluster seizures or status epilepticus
Its efficacy has not been shown in clusters or status and the product information does not recommend it for those dogs. Phenobarbital or combinations are preferred.
B. It requires serum level monitoring like phenobarbital
There is no established therapeutic range and level measurement is not recommended; adjustment is based on clinical response and the seizure diary.
C. It is a low-affinity partial agonist at the benzodiazepine site of the GABA-A receptor, licensed for dogs with idiopathic epilepsy
Correct. As a partial agonist it does not cause the tolerance or marked dependence seen with benzodiazepines. It does not induce liver enzymes and is usually well tolerated (transient polyphagia, ataxia or sedation).
D. It is licensed in cats as a first-choice alternative to phenobarbital
It is licensed only in dogs. In cats the first-choice antiepileptic remains phenobarbital.
lightbulb Key takeaway
Imepitoin is a good first option in dogs with idiopathic epilepsy and isolated generalised seizures, especially when hepatic induction is to be avoided. If insufficient, it can be combined with phenobarbital. As with all antiepileptics, withdrawal must be gradual.
Test yourself with 10 random questions
Neurology · 100 questions, a different test every time
Related questions
Updated: October 31, 2026 · Educational content for veterinary professionals. It does not replace current clinical guidelines or the judgement of the attending veterinarian.